{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:31:21Z","timestamp":1768516281077,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["APP1049884"],"award-info":[{"award-number":["APP1049884"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81328015"],"award-info":[{"award-number":["81328015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bcp.2016.02.013","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T14:01:50Z","timestamp":1456063310000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo"],"prefix":"10.1016","volume":"104","author":[{"given":"Xiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0194-6936","authenticated-orcid":false,"given":"Jun J.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euphemie","family":"Landao-Bassonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Pavlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Steer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming H.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2151-3433","authenticated-orcid":false,"given":"Tak S.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.02.013_b0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.013_b0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","article-title":"Osteoclasts: What do they do and how do they do it?","volume":"170","author":"Teitelbaum","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2016.02.013_b0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.013_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.013_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2016.02.013_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/me.2007-0465","article-title":"Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation","volume":"23","author":"Cheng","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2016.02.013_b0035","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2016.02.013_b0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2016.02.013_b0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2016.02.013_b0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejcb.2005.09.008","article-title":"Podosome and sealing zone: specificity of the osteoclast model","volume":"85","author":"Jurdic","year":"2006","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bcp.2016.02.013_b0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.013_b0060","doi-asserted-by":"crossref","first-page":"10236","DOI":"10.1074\/jbc.M111.321133","article-title":"Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p)","volume":"287","author":"Chan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.013_b0065","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1359\/jbmr.2000.15.11.2178","article-title":"Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand","volume":"15","author":"Xu","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2016.02.013_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034132","article-title":"Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption","volume":"7","author":"Qin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2016.02.013_b0075","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/9.13.2059","article-title":"Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis","volume":"9","author":"Kornak","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2016.02.013_b0080","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/nm1514","article-title":"V-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation","volume":"12","author":"Lee","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.013_b0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","article-title":"Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification","volume":"23","author":"Li","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2016.02.013_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027155","article-title":"Versatile roles of V-ATPases accessory subunit Ac45 in osteoclast formation and function","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2016.02.013_b0095","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.biocel.2012.05.014","article-title":"V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption","volume":"44","author":"Qin","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2016.02.013_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2016.02.013_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/15216540500137669","article-title":"RANKing intracellular signaling in osteoclasts","volume":"57","author":"Feng","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bcp.2016.02.013_b0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2016.02.013_b0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0736-0266(01)00088-2","article-title":"Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells","volume":"20","author":"Clohisy","year":"2002","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bcp.2016.02.013_b0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-0004.2010.01619.x","article-title":"Bone resorption in syndromes of the Ras\/MAPK pathway","volume":"80","author":"Stevenson","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcp.2016.02.013_b0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.emboj.7600564","article-title":"RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis","volume":"24","author":"Gohda","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2016.02.013_b0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.013_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","article-title":"NF-kappaB functions in osteoclasts","volume":"378","author":"Soysa","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2016.02.013_b0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","article-title":"Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts","volume":"148","author":"Miyazaki","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2016.02.013_b0145","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1","volume":"280","author":"Monje","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.013_b0150","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1359\/jbmr.2003.18.7.1198","article-title":"Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity","volume":"18","author":"Nakamura","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2016.02.013_b0155","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2016.02.013_b0160","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1074\/jbc.M104957200","article-title":"Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling","volume":"277","author":"Wei","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.013_b0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.02.013_b0170","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.013_b0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.02.013_b0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2016.02.013_b0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","article-title":"Regulation of NFATc1 in osteoclast differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bcp.2016.02.013_b0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI200419657","article-title":"Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation","volume":"114","author":"Ikeda","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.02.013_b0195","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1074\/jbc.M609723200","article-title":"MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation","volume":"282","author":"Sharma","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.013_b0200","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tibs.2015.08.005","article-title":"Recent insights into the structure, regulation, and function of the V-ATPases","volume":"40","author":"Cotter","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2016.02.013_b0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbabio.2014.01.018","article-title":"Eukaryotic V-ATPase: novel structural findings and functional insights","volume":"1837","author":"Marshansky","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2016.02.013_b0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gene.2005.12.012","article-title":"NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation","volume":"372","author":"Crotti","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2016.02.013_b0215","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jcp.21344","article-title":"PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter","volume":"215","author":"Crotti","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2016.02.013_b0220","doi-asserted-by":"crossref","first-page":"17660","DOI":"10.1074\/jbc.M311032200","article-title":"Src kinase activity is essential for osteoclast function","volume":"279","author":"Miyazaki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.013_b0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/s10165-006-0460-z","article-title":"The role of c-Src kinase in the regulation of osteoclast function","volume":"16","author":"Miyazaki","year":"2006","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bcp.2016.02.013_b0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-007-0773-9","article-title":"Involvement of alpha(v)beta3 integrins in osteoclast function","volume":"25","author":"Nakamura","year":"2007","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bcp.2016.02.013_b0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1083\/jcb.201410123","article-title":"Absence of Dap12 and the alphavbeta3 integrin causes severe osteopetrosis","volume":"208","author":"Zou","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2016.02.013_b0240","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bone.2004.04.023","article-title":"Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha","volume":"35","author":"Wada","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2016.02.013_b0245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcb.21167","article-title":"Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan","volume":"101","author":"Hotokezaka","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2016.02.013_b0250","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbrc.2007.06.023","article-title":"Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells","volume":"360","author":"Islam","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521600112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521600112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T20:54:05Z","timestamp":1536958445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521600112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":50,"alternative-id":["S000629521600112X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.02.013","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2016 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}